MGMT and central nervous system cancer: Previous work by Eich and colleagues showed that siRNA‐mediated knockdown of either ATR or ATM sensitised an MGMT‐negative glioma cell line to temozolomide [157], with similar findings for ATM also reported by Nadkarni et al.